共有 50 笔近期内部人交易记录记录,涉及 AcelRx Pharmaceuticals, Inc. (ACRX), 包括 25 笔买入 和 22 笔卖出. 内部人买入总额为 $693.35K 内部人卖出总额为 $81.94K.
近期活跃的重要内部人包括 Nantahala Capital Management, Llc, Angotti Vincent J., Hoffman Stephen J. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — ACRX
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2024-03-15 |
Nantahala Capital Management, Llc |
10 Percent Owner, Other: See Remarks |
未知 |
755,000 |
$5.00 |
$3.78M |
- |
| 2024-01-15 |
Nantahala Capital Management, Llc |
10 Percent Owner, Other: See Remarks |
未知 |
- |
- |
- |
1,237,519 |
| 2023-12-13 |
Angotti Vincent J. |
Chief Executive Officer |
知情买入 |
10,000 |
$0.73 |
$7.27K |
101,805 |
| 2023-10-10 |
Hoffman Stephen J |
Director |
限制性股票授予 (RSU) |
581 |
- |
- |
2,418 |
| 2023-10-10 |
Wan Mark A |
Director |
限制性股票授予 (RSU) |
581 |
- |
- |
2,418 |
| 2023-10-10 |
Adams Adrian |
Director |
限制性股票授予 (RSU) |
3,487 |
$0.68 |
$2.39K |
3,487 |
| 2023-10-10 |
Broadfoot Jill Marie |
Director |
限制性股票授予 (RSU) |
581 |
- |
- |
2,106 |
| 2023-10-10 |
Rosen Howard B |
Director |
限制性股票授予 (RSU) |
3,487 |
$0.68 |
$2.39K |
3,487 |
| 2023-10-10 |
Afable Richard |
Director |
限制性股票授予 (RSU) |
581 |
- |
- |
2,468 |
| 2023-10-10 |
Bozilenko Marina |
Director |
限制性股票授予 (RSU) |
581 |
- |
- |
2,606 |
| 2023-09-11 |
Angotti Vincent J. |
Chief Executive Officer |
知情买入 |
10,000 |
$0.80 |
$7.95K |
91,805 |
| 2023-08-25 |
Palmer Pamela P |
Chief Medical Officer |
知情卖出 |
7,442 |
$1.09 |
$8.1K |
30,753 |
| 2023-08-24 |
Palmer Pamela P |
Chief Medical Officer |
知情卖出 |
9,514 |
$1.17 |
$11.13K |
38,195 |
| 2023-07-20 |
Nantahala Capital Management, Llc |
10 Percent Owner, Other: See Remarks |
未知 |
750,883 |
$0.00 |
$750.88 |
- |
| 2023-03-03 |
Dasu Badri N |
Chief Engineering Officer |
RSU 预扣税 |
398 |
$1.31 |
$521.38 |
18,771 |
| 2023-03-03 |
Palmer Pamela P |
Chief Medical Officer |
RSU 预扣税 |
570 |
$1.31 |
$746.70 |
43,315 |
| 2023-03-03 |
Asadorian Raffi |
Chief Financial Officer |
RSU 预扣税 |
510 |
$1.31 |
$668.10 |
22,081 |
| 2023-03-03 |
Angotti Vincent J. |
Chief Executive Officer |
RSU 预扣税 |
1,703 |
$1.31 |
$2.23K |
63,836 |
| 2023-02-11 |
Dasu Badri N |
Chief Engineering Officer |
RSU 预扣税 |
776 |
$1.68 |
$1.3K |
19,169 |
| 2023-02-11 |
Palmer Pamela P |
Chief Medical Officer |
RSU 预扣税 |
1,017 |
$1.68 |
$1.71K |
43,885 |
| 2023-02-11 |
Asadorian Raffi |
Chief Financial Officer |
RSU 预扣税 |
873 |
$1.68 |
$1.47K |
22,591 |
| 2023-02-11 |
Angotti Vincent J. |
Chief Executive Officer |
RSU 预扣税 |
3,321 |
$1.68 |
$5.58K |
65,539 |
| 2023-02-10 |
Dasu Badri N |
Chief Engineering Officer |
限制性股票授予 (RSU) |
4,875 |
- |
- |
19,945 |
| 2023-02-10 |
Palmer Pamela P |
Chief Medical Officer |
限制性股票授予 (RSU) |
36,750 |
$1.76 |
$64.68K |
36,750 |
| 2023-02-10 |
Asadorian Raffi |
Chief Financial Officer |
限制性股票授予 (RSU) |
5,875 |
- |
- |
23,464 |
| 2023-02-10 |
Angotti Vincent J. |
Chief Executive Officer |
限制性股票授予 (RSU) |
19,500 |
- |
- |
68,860 |
| 2023-02-06 |
Dasu Badri N |
Chief Engineering Officer |
RSU 预扣税 |
458 |
$2.02 |
$925.16 |
15,070 |
| 2023-02-06 |
Palmer Pamela P |
Chief Medical Officer |
RSU 预扣税 |
681 |
$2.02 |
$1.38K |
38,777 |
| 2023-02-06 |
Asadorian Raffi |
Chief Financial Officer |
RSU 预扣税 |
617 |
$2.02 |
$1.25K |
17,589 |
| 2023-02-06 |
Angotti Vincent J. |
Chief Executive Officer |
RSU 预扣税 |
1,982 |
$2.02 |
$4K |
49,360 |
| 2022-07-15 |
Hoffman Stephen J |
Director |
限制性股票授予 (RSU) |
31,000 |
- |
- |
31,000 |
| 2022-07-15 |
Wan Mark A |
Director |
限制性股票授予 (RSU) |
15,500 |
- |
- |
36,750 |
| 2022-07-15 |
Adams Adrian |
Director |
限制性股票授予 (RSU) |
31,000 |
$0.23 |
$7.16K |
31,000 |
| 2022-07-15 |
Broadfoot Jill Marie |
Director |
限制性股票授予 (RSU) |
15,500 |
- |
- |
30,500 |
| 2022-07-15 |
Rosen Howard B |
Director |
限制性股票授予 (RSU) |
31,000 |
$0.23 |
$7.16K |
31,000 |
| 2022-07-15 |
Afable Richard |
Director |
限制性股票授予 (RSU) |
31,000 |
- |
- |
31,000 |
| 2022-07-15 |
Bozilenko Marina |
Director |
限制性股票授予 (RSU) |
31,000 |
- |
- |
31,000 |
| 2022-06-07 |
Angotti Vincent J. |
Chief Executive Officer |
知情买入 |
46,400 |
$0.22 |
$10.33K |
1,016,919 |
| 2022-03-03 |
Dasu Badri N |
Chief Engineering Officer |
RSU 预扣税 |
5,612 |
$0.41 |
$2.28K |
300,595 |
| 2022-03-03 |
Palmer Pamela P |
Chief Medical Officer |
RSU 预扣税 |
7,923 |
$0.41 |
$3.22K |
779,261 |
| 2022-03-03 |
Asadorian Raffi |
Chief Financial Officer |
RSU 预扣税 |
7,923 |
$0.41 |
$3.22K |
364,205 |
| 2022-03-03 |
Angotti Vincent J. |
Chief Executive Officer |
RSU 预扣税 |
23,051 |
$0.41 |
$9.38K |
970,519 |
| 2022-02-11 |
Dasu Badri N |
Chief Engineering Officer |
限制性股票授予 (RSU) |
195,000 |
$0.40 |
$78.27K |
195,000 |
| 2022-02-11 |
Palmer Pamela P |
Chief Medical Officer |
限制性股票授予 (RSU) |
245,000 |
$0.40 |
$98.34K |
245,000 |
| 2022-02-11 |
Asadorian Raffi |
Chief Financial Officer |
限制性股票授予 (RSU) |
235,000 |
$0.40 |
$94.33K |
235,000 |
| 2022-02-11 |
Angotti Vincent J. |
Chief Executive Officer |
限制性股票授予 (RSU) |
780,000 |
$0.40 |
$313.09K |
780,000 |
| 2022-02-06 |
Dasu Badri N |
Chief Engineering Officer |
RSU 预扣税 |
6,830 |
$0.43 |
$2.95K |
204,322 |
| 2022-02-06 |
Palmer Pamela P |
Chief Medical Officer |
RSU 预扣税 |
9,391 |
$0.43 |
$4.05K |
662,611 |
| 2022-02-06 |
Asadorian Raffi |
Chief Financial Officer |
RSU 预扣税 |
9,391 |
$0.43 |
$4.05K |
258,515 |
| 2022-02-06 |
Angotti Vincent J. |
Chief Executive Officer |
RSU 预扣税 |
27,318 |
$0.43 |
$11.78K |
616,628 |
■ 知情交易 — 公开市场买卖(最具参考价值)
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期